Discoveries announced today by St. Jude Children’s Research Hospital provide a scientific rationale for the targeted treatment of a type of pediatric medulloblastoma. Children who inherit a deficient ELP1 gene have an increased risk of developing SHH-medulloblastoma, a subtype of a malignant pediatric brain tumor.
This article was originally published on MedicalXpress.com